| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.29B | 42.41B | 33.27B | 30.80B | 29.46B | 28.12B |
| Gross Profit | 9.10B | 12.92B | 7.65B | 9.64B | 7.71B | 6.60B |
| EBITDA | 3.34B | 6.72B | 2.39B | 5.10B | 3.96B | 3.90B |
| Net Income | 1.90B | 3.44B | 1.31B | 2.74B | 2.22B | 2.31B |
Balance Sheet | ||||||
| Total Assets | 62.13B | 62.94B | 60.41B | 56.78B | 47.67B | 47.34B |
| Cash, Cash Equivalents and Short-Term Investments | 14.01B | 20.13B | 14.97B | 15.34B | 13.86B | 13.73B |
| Total Debt | 7.53B | 8.76B | 8.03B | 1.98B | 0.00 | 0.00 |
| Total Liabilities | 25.55B | 22.42B | 23.81B | 17.01B | 11.65B | 13.42B |
| Stockholders Equity | 36.34B | 40.26B | 36.39B | 39.42B | 35.72B | 33.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.44B | -759.00M | -140.00M | 1.02B | 2.32B |
| Operating Cash Flow | 0.00 | 4.10B | 50.00M | 525.00M | 1.25B | 2.69B |
| Investing Cash Flow | 0.00 | 813.00M | 154.00M | 116.00M | -392.00M | -714.00M |
| Financing Cash Flow | 0.00 | -360.00M | -329.00M | 1.20B | -848.00M | -848.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.03B | 11.83 | ― | 3.95% | 2.75% | 25.75% | |
80 Outperform | ¥69.54B | 12.92 | ― | 2.63% | 2.11% | 0.91% | |
74 Outperform | ¥92.04B | 16.92 | 7.00% | 3.02% | 8.49% | -0.33% | |
73 Outperform | ¥56.50B | 14.42 | ― | 2.54% | 3.47% | -12.26% | |
72 Outperform | ¥56.28B | 15.51 | ― | 2.09% | 27.49% | 173.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥66.84B | 11.56 | ― | 3.09% | 7.43% | 47.68% |